Tolterodine
- Generic Name
- Tolterodine
- Brand Names
- Detrol, Detrusitol
- Drug Type
- Small Molecule
- Chemical Formula
- C22H31NO
- CAS Number
- 124937-51-5
- Unique Ingredient Identifier
- WHE7A56U7K
- Background
Tolterodine is an antimuscarinic drug that is used to treat urinary incontinence. Tolterodine acts on M2 and M3 subtypes of muscarinic receptors.
- Indication
For the treatment of overactive bladder (with symptoms of urinary frequency, urgency, or urge incontinence).
- Associated Conditions
- Urinary Urge Incontinence
- Associated Therapies
- -
FDA greenlights pivotal trial of wearable bioelectronic device for OAB
FDA approves FemPulse's EVANESCE-II trial for its wearable FemPulse Ring, a bioelectronic device offering mild electrical nerve stimulation as a non-invasive alternative to pharmaceutical treatments for overactive bladder (OAB). The trial will compare the device's efficacy with tolterodine. Previous trials showed the device safe, comfortable, and effective, with potential for EU commercial availability by 2025.
Related Clinical Trials:
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath